# The <scp>pan‐JAK</scp> inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16‐week randomized phase <scp>IIb</scp> trial*

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-scp-pan-jak-scp-inhibitor-delgocitinib-in-a-cream-formulation-demonstrates/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Margitta Worm,Jacob P. Thyssen,Sibylle Schliemann,Andrea Bauer,Vivian Y. Shi,Ben Ehst,Sandra Tillmann,Sofie Korn,Katarina Resen,Tove Agner |
| Citations | 89 |
| DOI | 10.1111/bjd.21037 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1111/bjd.21037 |
| OpenAlex ID | https://openalex.org/W4210685488 |
| PMID | 35084738 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Vivian Y. Shi](https://scholariq.org/researchers/vivian-y-shi/)

## Paper journal

- [British Journal of Dermatology](https://scholariq.org/journals/british-journal-of-dermatology/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Contact Dermatitis and Allergies](https://scholariq.org/topics/contact-dermatitis-and-allergies/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.